Archived Newsletters

  1. 03.31.26 -- The Jones Act Hurts U.S. Pharmaceutical Manufacturing 3/31/2026
    03/31/26 Outsourced Pharma Newsletter
  2. 03.30.26 -- STREAM Insights Driving Innovation Across Pharma Development 3/30/2026
    03/30/26 Outsourced Pharma Newsletter
  3. 03.30.26 -- What If The U.S. Government Stopped Funding Biotech? 3/30/2026
    03/30/26 Outsourced Pharma Newsletter
  4. 03.27.26 -- Advising The Biotech C-Suite To Reconsider Quality 3/27/2026
    03/27/26 Outsourced Pharma Newsletter
  5. 03.26.26 -- The Hidden Obstacles Stalling Advanced Therapies 3/26/2026

    03/26/26 Outsourced Pharma Newsletter

  6. 03.26.26 -- A simple, helpful look at PUPSIT implementation. 3/26/2026

    03/26/26 Outsourced Pharma Newsletter

  7. 03.26.26 -- The Jones Act Hurts U.S. Pharmaceutical Manufacturing 3/26/2026
    03/26/26 Outsourced Pharma Newsletter
  8. 03.25.26 -- The Jones Act Hurts U.S. Pharmaceutical Manufacturing 3/25/2026
    03/25/26 Outsourced Pharma Newsletter
  9. 03.24.26 -- Is Your Sterile Injectable Strategy Built For Scale? 3/24/2026

    03/24/26 Outsourced Pharma Newsletter

  10. 03.24.26 -- The Long Road To U.S. Vaccine Manufacturing 3/24/2026
    03/24/26 Outsourced Pharma Newsletter